8-K: Supernus Pharmaceuticals, Inc. — Item 1.02 Termination of a Material Definitive Agreement
Filed: 2026-10-26 AccNo: 0001356576-26-000045 Size: 141 KB Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Ex